selected scholarly activity
-
chapters
- Personalized Symptom Management for Cancer Survivorship. 70-100. 2021
- Attending to the Quality of Life at the End of Life. Palliative Rehabilitation Is Person-Centered Care for Patients With Advanced Cancer. 161-175. 2019
- Chapter 15 Attending to the Quality of Life at the End of Life. Palliative Rehabilitation Is Person-Centered Care for Patients With Advanced Cancer. 161-175. 2019
- Rehabilitation and Survivorship. 635-651. 2018
- Cancer rehabilitation and fatigue. 97-110. 2012
- Rehabilitation in Cancer. 389-396. 2010
-
conferences
- ICES (International Carboplatin Emesis Survey) for the evaluation of the emetogenicity of continuous cycles of carboplatin-based chemotherapy with focus on nausea: A MASCC emesis study group, prospective, observational, real-world multi-centric study.. Journal of Clinical Oncology. e24086-e24086. 2021
- 1816MO ICES (International Carboplatin Emesis Survey) for the evaluation of the emetogenicity of carboplatin-based chemotherapy – with a focus on nausea. MASCC Antiemetic Study Group survey. Annals of Oncology. S1048-S1049. 2020
- Family Caregiver Experiences: A Case Study of Caregiving for an Advanced Cancer Patient Enrolled in a Palliative Rehabilitation Program. Journal of Pain and Symptom Management. e90-e91. 2018
- Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.. Journal of Clinical Oncology. 222-222. 2016
- Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers. Annals of Oncology. 2016
- Safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving breast cancer resistant protein (BCRP) substrate chemotherapy agents. Annals of Oncology. vi500-vi500. 2016
- Impact of rolapitant on quality of life (QoL) in patients (pts) receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC). Journal of Clinical Oncology. 2015
- Phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 trial.. Journal of Clinical Oncology. 6000-6000. 2015
- Physicians' attitudes toward systematic symptom assessment and management: Results from all regional cancer centres in Ontario (Canada).. Journal of Clinical Oncology. 2015
- Results from an interdisciplinary palliative rehabiliation program for patients living with advanced cancer.. Journal of Clinical Oncology. 9525-9525. 2014
- Results from a structured interprofessional palliative care rehabilitation program in oncology.. Journal of Clinical Oncology. 2013
- Perioperative chemotherapy for upper gastrointestinal cancer: Correlation between response to treatment and outcome.. Journal of Clinical Oncology. 95-95. 2012
- P2-15-05: Excision of the Primary Tumour in Patients with Metastatic Breast Cancer – Will E2108 Provide the Definitive Answer?. Cancer Research. 2011
- Current practise of parenteral nutrition (PN) in incurable cancer patients, having mild to severe bowel obstruction (BO) and cachexia (CC): development of an international case-vignette based survey of experienced clinicians. Onkologie: international journal for cancer research and treatment. 53-53. 2011
- Does removal of the primary tumor in patients with metastatic breast cancer improve either local control or overall survival?. Journal of Clinical Oncology. e11511-e11511. 2011
- The Impact Of A Pre-Operative Multidisciplinary Program On Improving Nutritional Reserve And Exercise Capacity In Lung Cancer Patients. C102. LUNG CANCER: RECENT ADVANCES IN STAGING, DIAGNOSIS, AND SURGICAL INTERVENTION. a5392-a5392. 2011
- Changing How Canadians and Health Providers Define Palliative Care: Palliative rehabilitation - does it really work?. Journal of Palliative Care. 254-254. 2010
- Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: Safety and response results from a multicenter phase II trial.. Journal of Clinical Oncology. 4075-4075. 2010
- Cost-effectiveness of cetuximab for the first-line treatment of squamous cell carcinoma of the head and neck (SCCHN) in Canada. Journal of Clinical Oncology. 2009
- Cost-effectiveness of cetuximab for the first-line treatment of squamous cell carcinoma of the head and neck (SCCHN) in Canada. Journal of Clinical Oncology. e17000-e17000. 2009
- Phase II study of AVR118 in the management of cancer related anorexia/cachexia. Journal of Clinical Oncology. 2009
- The McGill Cancer Nutrition and Rehabilitation Program. Journal of Clinical Oncology. 2009
- The management of dysphagia in esophageal cancer patients undergoing neoadjuvant chemotherapy: Is invasive tube feeding required?. Journal of Clinical Oncology. 2009
- PCN68 COST-EFFECTIVENESS OF CETUXIMAB (ERBITUXTM) FOR THE FIRST LINE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN CANADA. Value in Health. A49-A49. 2009
- Randomized control trial of the Meaning-Making intervention (MMi) for people newly diagnosed with advanced ovarian cancer: a pilot study. Journal of Palliative Care. 198-198. 2008
- Cancer nutrition and rehabilitation: a program that works. Journal of Palliative Care. 201-201. 2007
- NCIC sociobehavioural cancer research network-clinical trials group: Cancer pain classification project: Pilot and feasibility phaser. Journal of Palliative Care. 199-199. 2007
- Pilot study of the meaning-making intervention for family caregivers of patients with advanced stage cancer. Psycho-Oncology. S216-S217. 2007
- Randomized control trial of the meaning-making intervention in people newly diagnosed with advanced ovarian cancer: A pilot study. Journal of Palliative Care. 199-199. 2007
- Recognizing, treating, evaluating and sharing the intangible search for meaning within a team approach: Implications of the meaning-making intervention. Psycho-Oncology. S116-S116. 2007
- Assessing and managing cancer cachexia: What's up. Journal of Palliative Care. 204-204. 2006
- Use of venous access devices in patients with cancer younger than 21 years of age. Journal of Palliative Care. 223-224. 2005
- Use of venous access devices in patients younger than 21 years of age. Annals of Oncology. 321-321. 2005
- Quality of life in practice. Psycho-Oncology. S81-S81. 2003
- Phase II study of pegylated liposomal doxorubicin (Caelyx) in advanced hepatocellular carcinoma (HHC).. Annals of Oncology. 69-70. 2000
- Assessment of alternative and complimentary medicines and devices in cancer patients attending a multi-disciplinary cancer centre. European Journal of Cancer. S17-S18. 1999
- Comparison of initial clinical characteristics between Asian and Italian multiple myeloma (MM) patients entering the International Oncology Study Group (IOSG) MM1 and the Italian MM study group protocols.. Blood. 3586-3586. 1996
-
journal articles
- Results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy.. Journal of Clinical Oncology. 42:LBA12007-LBA12007. 2024
- Cancer anorexia‐cachexia syndrome is characterized by more than one inflammatory pathway. Journal of Cachexia, Sarcopenia and Muscle. 15:1041-1053. 2024
- Corrigendum to ‘Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent’. ESMO Open. 7:100614-100614. 2022
- Experiences and Lessons Learned from Implementing the RELIEF Digital Symptom Self-Reporting App in a Palliative Home Care Setting. Current Oncology. 29:9401-9406. 2022
- Utilization of Point-of-Care Ultrasound in a Specialist Palliative Care Team Across Multiple Care Settings: A Retrospective Chart Review. Palliative Medicine Reports. 3:229-234. 2022
- Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care. Supportive Care in Cancer. 30:3073-3083. 2022
- RELIEF: A Digital Health Tool for the Remote Self-Reporting of Symptoms in Patients with Cancer to Address Palliative Care Needs and Minimize Emergency Department Visits. Current Oncology. 28:4273-4280. 2021
- Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis. Journal of Cachexia, Sarcopenia and Muscle. 12:1189-1202. 2021
- Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆. ESMO Open. 6:100092-100092. 2021
- Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020. Supportive Care in Cancer. 29:2841-2850. 2021
- Perceptions of palliative care in a South Asian community: findings from an observational study. BMC Palliative Care. 19:141. 2020
- The effect of ginger (Zingiber officinale Roscoe) in patients with advanced cancer. Supportive Care in Cancer. 28:3279-3286. 2020
- Inflammatory Markers as Prognostic Factors of Recurrence in Advanced-Stage Squamous Cell Carcinoma of the Head and Neck. Current Oncology. 27:135-141. 2020
- Effects of a Cancer Survivorship Clinic—preliminary results. Supportive Care in Cancer. 28:2381-2388. 2020
- Psychedelics for Psychological and Existential Distress in Palliative and Cancer Care. Current Oncology. 26:225-226. 2019
- REFLECTIONS ON CANCER REHABILITATION AND SURVIVORSHIP IN CANADA: OBSERVING TEN YEARS OF EVIDENCE INFORMED PRACTICE. Journal of Cancer Rehabilitation. 2:18-23. 2019
- A Little Help from My Friends: Social Support in Palliative Rehabilitation. Current Oncology. 25:358-365. 2018
- Moving Research Into Practice: Summary Report of the Ex/Cancer Meeting on Physical Activity, Exercise, and Rehabilitation in Oncology. Current Oncology. 25:615-621. 2018
- Exercise as part of routine cancer care. The Lancet Oncology. 19:e432-e432. 2018
- Exercise as part of routine cancer care. The Lancet Oncology. 19:e433-e436. 2018
- Comprehensive Metastatic Lung Cancer Care Must Include Palliative Care. Current Oncology. 25:192-193. 2018
- Palliative Care: Who is Responsible?. Journal of the National Comprehensive Cancer Network : JNCCN. 16:791-792. 2018
- Connecting People with Cancer to Physical Activity and Exercise Programs: A Pathway to Create Accessibility and Engagement. Current Oncology. 25:149-162. 2018
- Reported distress in patients living with advanced cancer: changes pre-post interdisciplinary palliative rehabilitation. Supportive Care in Cancer. 25:3191-3197. 2017
- The longitudinal course of depression symptomatology following a palliative rehabilitation program. Quality of Life Research. 26:1809-1818. 2017
- Quality of Life for Patients Surviving Cancer: Are We Moving Ahead?. Current Oncology. 24:151-152. 2017
- Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma. JAMA Oncology. 3:220-220. 2017
- Introducing Dr. Matthew Seftel. Current Oncology. 24:7-7. 2017
- Oncology Nurses’ Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study. Oncology Nursing Forum. 44:116-125. 2017
- Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations. Drug Design, Development and Therapy. Volume 11:2621-2629. 2017
- Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy. Supportive Care in Cancer. 25:85-92. 2017
- Early Palliative Care: Taking Ownership and Creating the Conditions. Current Oncology. 23:367-370. 2016
- Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers. Annals of Oncology. 27:vi499-vi499. 2016
- Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada. Journal of Pain and Symptom Management. 51:662-672.e8. 2016
- Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy. Journal of Clinical Oncology. 57:23-30. 2016
- Rolapitant for the Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review of the Clinical Evidence. Future Oncology. 12:763-778. 2016
- An interdisciplinary palliative rehabilitation intervention bolstering general self-efficacy to attenuate symptoms of depression in patients living with advanced cancer. Supportive Care in Cancer. 24:109-117. 2016
- Worth His Weight in .... Current Oncology. 22:372-373. 2015
- Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of highly or moderately emetogenic chemotherapy (HEC, MEC).. Journal of Clinical Oncology. 33:210-210. 2015
- Are Patients Receiving the Right Care in the Right Place at the Right Time?. Current Oncology. 22:315-316. 2015
- 1525 Rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV): Efficacy and safety over multiple cycles of highly or moderately emetogenic chemotherapy. European Journal of Cancer. 51:S212-S213. 2015
- Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials. The Lancet Oncology. 16:1079-1089. 2015
- Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial. The Lancet Oncology. 16:1071-1078. 2015
- Impact of rolapitant on quality of life (QoL) in patients (pts) receiving highly emetogenic chemotherapy (HEC) and moderately emetogenic chemotherapy (MEC).. Journal of Clinical Oncology. 33:9615-9615. 2015
- Physicians’ attitudes toward systematic symptom assessment and management: Results from all regional cancer centres in Ontario (Canada).. Journal of Clinical Oncology. 33:e17678-e17678. 2015
- Erratum: Tumour Inflammatory Response: Adding Fuel to the Fire?. Current Oncology. 22:133-133. 2015
- Attitudes of oncologists towards palliative care and the Edmonton Symptom Assessment System (ESAS) at an Ontario cancer center in Canada. Supportive Care in Cancer. 23:769-778. 2015
- Tumour Inflammatory Response: Adding Fuel to the Fire?. Current Oncology. 22:7-9. 2015
- Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss. Journal of Clinical Oncology. 33:90-99. 2015
- Immunomodulatory agents for the treatment of cachexia. Current opinion in supportive and palliative care. 8:328-333. 2014
- Pedometer-facilitated walking intervention shows promising effectiveness for reducing cancer fatigue: a pilot randomized trial. Clinical Rehabilitation. 28:1198-1209. 2014
- Rehabilitation for patients with advanced cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:1071-1075. 2014
- Phase 3 (P04832) Trial Results for Rolapitant, a Novel Nk-1 Receptor Antagonist, in the Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) in Patients Receiving Cisplatin-Based Chemotherapy. Annals of Oncology. 25:v1-v1. 2014
- A Prospective Evaluation of an Interdisciplinary Nutrition–Rehabilitation Program for Patients with Advanced Cancer. Current Oncology. 20:310-318. 2013
- An Interprofessional Palliative Care Oncology Rehabilitation Program: Effects on Function and Predictors of Program Completion. Current Oncology. 20:301-309. 2013
- Rehabilitation following cancer treatment. Disability and Rehabilitation. 35:2245-2258. 2013
- The Association between Malnutrition and Psychological Distress in Patients with Advanced Head-and-Neck Cancer. Current Oncology. 20:554-560. 2013
- Results from a structured interprofessional palliative care rehabilitation program in oncology.. Journal of Clinical Oncology. 31:e20598-e20598. 2013
- The growing pains of cancer survivors: a call for a paradigm of interdisciplinary care.. Current Oncology. 20:e57-e58. 2013
- Effect of an interdisciplinary rehabilitation program on quality of life in patients with head and neck cancer: Review of clinical experience. Head and Neck. 35:343-349. 2013
- Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome. Medical Oncology. 30:377. 2013
- Consensus Recommendations for Cancer Rehabilitation: Research and Education Priorities. Current Oncology. 20:64-69. 2013
- Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. Journal of Cancer Survivorship. 6:359-371. 2012
- Excision of the Primary Tumour in Patients with Metastatic Breast Cancer: A Clinical Dilemma. Current Oncology. 19:270-279. 2012
- Effect of exercise in reducing breast and chest-wall pain in patients with breast cancer: a pilot study. Current Oncology. 19:129-135. 2012
- Gastrointestinal symptoms, electrogastrography, inflammatory markers, and PG-SGA in patients with advanced cancer. Supportive Care in Cancer. 20:1283-1290. 2012
- Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial. Annals of Oncology. 23:1512-1517. 2012
- A Call for Action in Survivorship Research and Care. Current Oncology. 19:16-20. 2012
- In This Issue of Current Oncology. Current Oncology. 19:125-126. 2012
- Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck. Current Medical Research and Opinion. 27:2253-2259. 2011
- Survivorship Services for Adult Cancer Populations: A Pan-Canadian Guideline. Current Oncology. 18:265-281. 2011
- Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Annals of Oncology. 22:2086-2093. 2011
- Phase II Study of the Novel Peptide-Nucleic Acid OHR118 in the Management of Cancer-Related Anorexia/Cachexia. Journal of the American Medical Directors Association. 12:62-67. 2011
- A retrospective study of the role of an occupational therapist in the cancer nutrition rehabilitation program. Supportive Care in Cancer. 18:1589-1596. 2010
- Terry Fox's legacy: a case for translational research. Current Oncology. 17:262-263. 2010
- The Meaning‐Making intervention (MMi) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study. Psycho-Oncology. 19:1340-1347. 2010
- Cancer Nutrition Rehabilitation Program: The Role of Social Work. Current Oncology. 17:12-17. 2010
- Terry Fox’s Legacy: A Case for Translational Research. Current Oncology. 17:2-3. 2010
- A rehabilitation program for patients with gastroesophageal cancer—a pilot study. Supportive Care in Cancer. 18:35-40. 2010
- Editorial—Nutrition as supportive care in the cancer experience. Supportive Care in Cancer. 18:11-12. 2010
- Every Patient Tells a Story. Journal of Pain and Symptom Management. 39:612-613. 2010
- Prevalence of emotional distress in newly diagnosed lung cancer patients. Supportive Care in Cancer. 17:1493-1497. 2009
- A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Supportive Care in Cancer. 17:1345-1351. 2009
- European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliative Medicine. 23:581-593. 2009
- Abstracts of presentations to the Annual Meetings of the Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons Canadian Hepato-Pancreato-Biliary Society Canadian Society of Surgical Oncology Canadian Society of Colon and Rectal Surgeons: Victoria, BC Sept. 10-13, 2009.. Canadian Journal of Surgery. 52:S1-S48. 2009
- Rehabilitation: Long-Term Physical and Functional Changes Following Treatment. Seminars in Oncology Nursing. 25:222-230. 2009
- The McGill Cancer Nutrition and Rehabilitation Program. Journal of Clinical Oncology. 27:9623-9623. 2009
- The management of dysphagia in esophageal cancer patients undergoing neoadjuvant chemotherapy: Is invasive tube feeding required?. Journal of Clinical Oncology. 27:9613-9613. 2009
- Chemotherapy-Induced Small Bowel Perforation in a Patient with Extrapulmonary Small-Cell Carcinoma of the Small Bowel. Current Oncology. 15:298-301. 2008
- Healing and Survivorship: What Makes a Difference?. Current Oncology. 15:185-187. 2008
- Cancer Nutrition and Rehabilitation—Its Time Has Come!. Current Oncology. 15:117-122. 2008
- Chemotherapy-induced small bowel perforation in a patient with extrapulmonary small-cell carcinoma of the small bowel. Current Oncology. 15:44-47. 2008
- Healing and survivorship: What makes a difference?. Current Oncology. 15:20-22. 2008
- Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93. Annals of Oncology. 18:1177-1184. 2007
- Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Annals of Oncology. 16:716-725. 2005
- First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study. Breast. 13:219-226. 2004
- ESMO takes a stand on supportive and palliative care. Annals of Oncology. 14:1335-1337. 2003
- Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy. International Journal of Gynecological Cancer. 13:287-291. 2003
- Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy. International Journal of Gynecological Cancer. 13:287-291. 2003
- [Hairy cell leukemia, a reality in the Congo; apropos of 10 cases].. Bulletin de la Societe de Pathologie Exotique. 96:115-118. 2003
- Phase II trial of gemcitabine and vinorelbine in patients with stage III B and IV non small cell lung cancer. Clinical and Translational Oncology. 5:21-26. 2003
- Carboplatin hypersensitivity presenting as coronary vasospasm - a case report. Cancer Chemotherapy and Pharmacology. 50:429-431. 2002
- Malignant pleural mesothelioma: a phase II trial with docetaxel. Annals of Oncology. 13:412-415. 2002
- Gemzar and Navelbine in the treatment of patients with stage III b and IV non-small cell lung cancer. A phase II trial. Lung Cancer. 29:31-31. 2000
- Taxotere in malignant pleural mesothelioma. A phase II clinical trial. Lung Cancer. 29:19-19. 2000
- A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study. Leukemia and Lymphoma. 37:367-377. 2000
- P14 Outcome of high risk melanoma patients treated with low dose interferon alpha 2B. Melanoma Research. 9:328-328. 1999
- The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line.. Oncology Reports. 6:217-218. 1999
- A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma. Annals of Oncology. 9:217-219. 1998
- Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis.. Anticancer Research. 15:559-562. 1995
- Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease.. Anticancer Research. 13:2229-2237. 1993
- Leukemia after Chemotherapy for Cancer. Cancer Biotherapy. 8:115-122. 1993
- COMBINED CONGRESS OF SA MEDICAL ONCOLOGISTS AND RADIOLOGISTS, APRIL 1992. SAMJ - South African Medical Journal. 82:65-66. 1992
- Successful Treatment of Gold-induced Aplastic Anaemia with Granulocyte Macrophage Colony Stimulating Factor. Rheumatology. 31:428-429. 1992
- Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer. Investigational New Drugs. 8:215-219. 1990
- Prognostic factors in patients with small-cell carcinoma of the lung.. SAMJ - South African Medical Journal. 70:812-814. 1986
- Hypothyroidism presenting as growth retardation. A case report.. SAMJ - South African Medical Journal. 69:193-195. 1986
- A call for action in survivorship research and care. Current Oncology. 19:16-20.
- Examining Guidelines and New Evidence in Oncology Nutrition: a Position Paper on Gaps and Opportunities in Multimodal Approaches to Improve Patient Care. Kompass Nutrition & Dietetics. 3:3-9.
-
preprints